However, it is still a matter of contention if BCR-ABL transcript-level data observed in the defined time points may be significantly predictive for the long-term outcome of CML patients treated with IM first line and might improve or even replace the prognostic significance of cytogenetic data 10,11. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.